We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesHeartflow, Inc. Common Stock

Heartflow, Inc. Common Stock

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
58.57 USD -0.53 ( 0.90%)
Last update at 2026-11-12T15:40:00Z
VOLUME
1031493
Market Cap
4202.47M

Momentum Score

…

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in San Francisco, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
57.53
Low
59.97
High
52 Week Price Range
20.13
Low
51.78
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

HeartFlow provides a non-invasive cardiac diagnostic service that converts coronary CT scans into patient-specific 3D models and fractional flow reserve estimates to support coronary artery disease diagnosis. Long-term growth may be supported by aging populations, wider adoption of non-invasive testing, expanding reimbursement and hospital partnerships; investors may find the company attractive for potential recurring, scalable revenue and exposure to clinical AI in cardiology.

Material risks include dependence on reimbursement and regulatory decisions, the need for sustained clinician adoption amid competition, and ongoing profitability and financing uncertainty.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
59.10
Dividend Yield
-
Revenue TTM
212.07M
Revenue Per Share
2.76
Gross Profit TTM
169.83M
Debt / Equity
0.07
ROE
-154.23%
Net Debt
-22.72M
ROCE
-32.07%
Diluted EPS TTM
-3.08

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Income before tax -116.87M -96.37M -95.11M
Net income -116.79M -96.43M -95.66M
Selling general administrative 134.34M 112.15M 95.11M
Gross profit 135.20M 94.45M 58.05M
Reconciled depreciation 8.57M 8.13M 7.59M
Ebit -101.69M -73.61M -70.41M
Ebitda -93.12M -65.47M -62.83M
Depreciation and amortization 8.57M 8.13M 7.59M
Operating income -64.07M -61.22M -72.91M
Other operating expenses 240.10M 187.03M 160.09M
Interest expense 15.17M 22.77M 24.69M
Tax provision -0.08M 0.05M 0.55M
Interest income 5.54M 4.07M 5.46M
Net interest income -9.63M -18.70M -19.24M
Income tax expense -0.08M 0.05M 0.55M
Total revenue 176.03M 125.81M 87.17M
Total operating expenses 199.26M 155.67M 130.97M
Cost of revenue 40.84M 31.36M 29.12M
Total other income expense net -52.80M -35.15M -22.19M
Net income from continuing ops -116.79M -96.43M -95.66M
Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Total assets 359.45M 118.70M 185.05M
Intangible assets - 7.77M 7.95M
Other current assets 14.07M 3.83M 3.18M
Total liab 58.80M 978.19M 962.62M
Total stockholder equity 300.65M -859.48M -777.56M
Other current liab 32.65M 24.28M 22.68M
Common stock 0.09M 0.01M 0.01M
Capital stock 0.09M 0.01M 0.01M
Retained earnings -1087.75M -970.96M -874.53M
Cash 44.78M 51.37M 122.77M
Total current liabilities 42.37M 33.60M 32.81M
Current deferred revenue 0.63M 1.04M 2.11M
Net debt -22.72M 109.02M 37.83M
Short term debt 5.92M 5.42M 5.14M
Short long term debt total 22.05M 160.38M 160.60M
Other stockholder equity 1388.74M 112.24M 97.47M
Total current assets 220.20M 82.29M 148.45M
Long term investments 103.36M 0.00M -
Short term investments 132.01M 0.00M -
Net receivables 29.34M 27.09M 22.50M
Long term debt - 136.43M 134.01M
Accounts payable 3.17M 2.87M 2.89M
Accumulated other comprehensive income -0.42M -0.77M -0.50M
Non currrent assets other 9.81M 8.69M 5.72M
Non current assets total 139.25M 36.42M 36.60M
Capital lease obligations 22.05M 23.95M 26.59M
Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Investments -233.54M -4.36M -6.11M
Total cashflows from investing activities -238.57M -4.36M -6.11M
Net borrowings -42.37M 0.00M 0.00M
Total cash from financing activities 286.04M 2.24M 169.32M
Net income -116.79M -96.43M -95.66M
Change in cash -6.74M -71.39M 86.28M
Begin period cash flow 51.52M 127.23M 40.96M
End period cash flow 44.78M 55.84M 127.23M
Total cash from operating activities -54.02M -69.00M -76.43M
Issuance of capital stock 332.39M 0.00M 168.96M
Depreciation 8.57M 8.13M 7.59M
Change to account receivables -4.89M -3.85M -9.35M
Sale purchase of stock 0.00M 0.00M -0.23M
Other cashflows from financing activities -0.51M 2.24M 169.55M
Capital expenditures 5.03M 4.36M 6.11M
Change in working capital -7.66M -10.88M -8.54M
Stock based compensation 13.96M 10.21M 11.87M
Other non cash items 47.89M 19.96M 8.30M
Free cash flow -59.05M -73.36M -82.54M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
HTFL
Heartflow, Inc. Common Stock		 -0.53
0.90%		 58.57 - - 19.82 15.40 19.67
VEEV
Veeva Systems Inc Class A		 -4.88
1.60%		 299.89 43.49 29.59 12.48 5.79 10.39
PMCUF
Pro Medicus Limited		 0.68
0.48%		 142.50 64.90 90.91 49.11 38.05 65.12
TEM
Tempus AI, Inc. Class A Common Stock		 -4.81
6.06%		 74.62 - - 8.68 25.39 8.33
MTHRY
M3 Inc		 -0.07
1.22%		 5.66 31.84 26.25 0.05 4.60 0.04

Profile*

Heartflow, Inc. Common Stock

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in San Francisco, California.

135 Main Street, San Francisco, CA, United States, 94105

650 241 1221

https://www.heartflow.com

843

Name Title Year Born
Mr. John C.M. Farquhar President, CEO & Director 1973
Mr. Vikram Verghese C.F.A. Chief Financial Officer 1985
Dr. Campbell D.K. Rogers FACC, M.D. Chief Medical Officer & Executive VP 1961
Dr. John Henry Stevens M.D. Co-Founder 1961
Ms. Kathleen Carey Senior Vice President of Operations NA
Mhairi L. Jones Chief Accounting Officer NA
Mr. Justin Cambra Chief Technology Officer NA
Mr. Nicholas S. Laudico Vice President of Investor Relations NA
Ms. Angela Ahmad J.D. Chief Legal & Compliance Officer NA
Mr. Shivanth Bhaskaran Chief Commercial Operations & Customer Success Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…